Soligenix
SNGX
#10275
Rank
S$15.85 M
Marketcap
S$1.57
Share price
-1.20%
Change (1 day)
-49.60%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -S$16.34 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$11.91 Million a decrease over its 2023 earnings that were of -S$9.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$16.34 Million37.27%
2024 -S$11.91 Million22.96%
2023 -S$9.68 Million-45.74%
2022 -S$17.84 Million11.88%
2021 -S$15.95 Million-32.37%
2020 -S$23.58 Million83.18%
2019 -S$12.87 Million11.57%
2018 -S$11.54 Million19.29%
2017 -S$9.67 Million33%
2016 -S$7.27 Million-19.7%
2015 -S$9.06 Million5.16%
2014 -S$8.61 Million
2010 -S$9.72 Million26.12%
2009 -S$7.71 Million75.1%
2008 -S$4.4 Million-45.38%
2007 -S$8.06 Million-22.84%
2006 -S$10.44 Million66.15%
2005 -S$6.29 Million-16.65%
2004 -S$7.54 Million13.28%
2003 -S$6.66 Million-11.88%
2002 -S$7.56 Million-59.44%
2001 -S$18.62 Million378.18%
2000 -S$3.9 Million-38.53%
1999 -S$6.34 Million-18.43%
1998 -S$7.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.24 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.08 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.58 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-S$23.12 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.17 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.25 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-S$3.51 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA